Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | 0 | 2 | 488 | 3 |
| Accounts receivable | 2 | 36 | -7 | 78 | -66 |
| Other Working Capital | -38 | -57 | 437 | 437 | -1,198 |
| Other Operating Activity | -320 | -339 | -2,386 | -6,618 | -1,576 |
| Operating Cash Flow | $-356 | $-360 | $-1,955 | $-5,615 | $-2,838 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -98 | -9 |
| Net Acquisitions | N/A | N/A | N/A | 384 | 1,154 |
| Purchase Of Investment | N/A | N/A | 0 | -406 | -248 |
| Sale Of Investment | 0 | 4 | 634 | 21 | 185 |
| Other Investing Activity | 0 | 20 | -48 | 0 | 0 |
| Investing Cash Flow | $0 | $24 | $586 | $-99 | $1,082 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | 0 | -3 |
| Common Stock Issued | N/A | N/A | 0 | 3,083 | 4,433 |
| Other Financing Activity | 148 | 0 | 0 | 1,893 | 0 |
| Financing Cash Flow | $148 | $0 | $0 | $4,976 | $4,430 |
| Beginning Cash Position | 345 | 680 | 2,049 | 2,787 | 113 |
| End Cash Position | 136 | 345 | 680 | 2,049 | 2,787 |
| Net Cash Flow | $-208 | $-336 | $-1,369 | $-738 | $2,674 |
| Free Cash Flow | |||||
| Operating Cash Flow | -356 | -360 | -1,955 | -5,615 | -2,838 |
| Capital Expenditure | N/A | N/A | N/A | -98 | -9 |
| Free Cash Flow | -356 | -360 | -1,955 | -5,713 | -2,847 |